The Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was the lead site for a study evaluating Phase I and Phase III clinical trials for elacestrant, a treatment for postmenopausal women and adult men with ER+/HER2- advanced or metastatic breast cancer. The U.S. Food and Drug Administration on Jan. 27 announced it approved the […]

Anton Fries, MD, PhD, chief, Division of Plastic and Reconstructive Surgery, was interviewed for this news segment.   Watch Now

  Amelie Ramirez, DrPH, MPH, leader of Salud America! at UT Health San Antonio, is among 15 new inductees to the San Antonio Women’s Hall of Fame. The San Antonio Women’s Hall of Fame has annually inducted women from Bexar and surrounding counties who have shaped the future of San Antonio and paved the way for women […]

Mays Cancer Center at UT Health San Antonio melanoma expert Monte Shaheen, MD, was part of a team of investigators that conducted a phase II clinical trial to determine the efficacy and safety of administering the immunotherapy drug pembrolizumab before and after surgery in high-risk melanoma patients.

Colorectal cancer begins in the colon or rectum and typically develops slowly over several years, starting as small, noncancerous growths called

The UT Health San Antonio Multispecialty and Research Hospital is expected to open in 2024. When complete, the hospital will be eight stories tall; will house 12 operating rooms, 144 beds and state-of-the-art technology; and have a sky bridge connecting it to the Mays Cancer Center, home to UT Health San Antonio MD Anderson. The […]